Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1988-10-24
|
pubmed:abstractText |
In the present report we describe the isolation and characterization of stable, long-term, human T-lymphocyte clones specific for myelin basic protein (MBP) from multiple sclerosis (MS) patients. Isolation of these clones appeared possible only by seeding peripheral blood mononuclear cells into a limiting dilution microculture system containing MBP, autologous irradiated cells and Interleukin-2 (IL-2), thereby minimizing effects of putative suppressor cell populations. All clones obtained were of the CD4+ phenotype. The majority was capable of MBP-specific cytolysis, tested with 51Chromium-labeled autologous Epstein-Barr virus (EBV)-transformed B-cells, coated with MBP, as targets. A few other clones had natural killer (NK) function. All clones produced Interleukin-2 (IL-2) upon adequate stimulation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0198-8859
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
97-109
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2458331-Antigens, Differentiation, T-Lymphocyte,
pubmed-meshheading:2458331-Cell Separation,
pubmed-meshheading:2458331-Clone Cells,
pubmed-meshheading:2458331-Humans,
pubmed-meshheading:2458331-Interleukin-2,
pubmed-meshheading:2458331-Multiple Sclerosis,
pubmed-meshheading:2458331-Myelin Basic Proteins,
pubmed-meshheading:2458331-Phenotype,
pubmed-meshheading:2458331-T-Lymphocytes, Cytotoxic
|
pubmed:year |
1988
|
pubmed:articleTitle |
Myelin basic protein-specific CD4+ cytolytic T-lymphocyte clones isolated from multiple sclerosis patients.
|
pubmed:affiliation |
Department of Neurology, Academic Hospital Maastricht, University of Limburg, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|